Psychopharmacology and applied behavioral analysis: Tandem treatment of severe problem behaviors in intellectual disability and a case series

Israel Journal of Psychiatry and Related Sciences

Volumn 43, Issue 4, 2006, Pages 265-274

  Wachter, Lee E ^a,b   Hagopian, Louis P ^a,b  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846815340     PISSN: 03337308     EISSN: 26172402     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Paclawskyj TR, Kurtz PF, O'Connor JT. Functional assessment of problem behaviors in adults with mental retardation. Behav Modif 2004;28:649-667.
2. Borthwick-Duffy S. Epidemiology and prevalence of psychopathology in people with mental retardation, J Consult Clin Psychol 1994;62:17-27.
3. Eyman RK, Borthwick-Duffy SA, Miller C. Trends in maladaptive behavior of mentally retarded persons placed in community and institutional settings. Am J Ment Defic 1981;85:473-477.
4. Borthwick-Duffy SA, Lane KL, Widaman KF. Measuring problem behaviors in children with mental retardation. Res Dev Disabil 1997;18:415-433.
5. McIntyre LL, Blacher J, Baker BL. Behaviour/mental health problems in young adults with intellectual disability: The impact on families. J Intell Disabil Res 2002;46:239-249.
6. Maison JL, Sevin JA. Theories of dual diagnosis in mental retardation. J Consult Clin Psychol 1994;62:6-16.
7. MacLean WE. Overview. In Maison JL, Barretl RP, edilors. Psychopathology of the menially retarded, Second Edition. Massachusetts: Allyn and Bacon, 1993.
8. Rutler M, Tizard J, Yule W, Graham P, Whilmore K. Research report: Isle of Wight Studies, 1964-1974. Psychol Med 1976;6:313-332.
9. American Psychiatric Association. Diagnostic Criteria from the DSM-IV-TR. Washington, DC, 2000.
10. Matson JL, Kazdin AE, Senatore V. Psychometric properties of the psychopathology instrument for mentally relarded adulls. Appl Res Ment Retard 1984;5:81-89.
11. Reiss S, Valenti-Hein D. Development of a psychopathology rating scale for children with mental retardation. J Consult Clin Psychol 1994;62:28-33.
12. Harris JC. Developmental neuropsychialry, Volume II: Assessment, diagnosis and trealment of developmental disorders. New York: Oxford University, 1998.
13. Schroeder SR, Osler-Granile ML, Berkson G, Bodfish JW, Breese GR, Calaldo MF, Cook EH, Crnic LS, DeLeon I, Fisher W, Harris JC, Horner RH, Iwata B, Jinnah HA, King BH, Lauder JM, Lewis MH, Newell K, Nyhan WL, Rojahn J, Sackett GP, Sandman C, Symons F, Tessel RE, Thompson T, Wong DF. Self-injurious behavior: Gene-brain-behavior relalionships. Ment Retard Dev Disabil Res Rev 2001;17:3-12.
14. Wong DF, Harris JC, Naidu K, Yokoi F, Marenco S, Dannals RF, Ravert HT, Yaster M, Evans A, Rousset O, Bryan RN, Gjedde A, Kuhar MJ, Breese GR. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci 1996;93:5539-5543.
15. MacIntyre DJ, Blackwood DHR, Porteous DJ, Pickard BS, Muir WJ. Chromosomal abnormalities and mental illness. Mol Psych 2003:8:275-287.
16. McClintock K, Hall S, Oliver C. Risk markers associated with challenging behaviours in people with intellectual disabilities: A meta-analytic study. J Intell Disabil Res 2003;47:405-416.
17. Sloman KN, Vollmer TR, Cotnoir NM, Borrero CSW, Borrero JC, Smaha AL, St Peter CC. Descriptive analyses of caregiver reprimands. J Appl Behav Anal 2005; 38:373-383.
18. Iwata BA, Pace GM, Dorsey MF, Zarcone JR, Volmmer TR, Smith RG. The functions of self-injurious behavior; an experimental-epidemiological analysis. J Appl Behav Anal 1994;27:215-240.
19. American Association of Mental Retardation. Treatment of psychiatric and behavioral problems in mental retardation 2000;105:165-188.
20. Baumeister AA, Sevin JA. Pharmacologic control of aberrant behavior in the mentally retarded: Toward a more rational approach. Neurosci and Biobehav Rev 1989;14: 253-262.
21. Matson JL, Bamburg JW, Mayville EA, Pinkston J, Bielecki J, Kuhn DE, Smalls Y, Logan JR. Psychopharmacology and mental retardation: A 10-year review (1990-1999). Res Dev Disabil 2000;21: 263-296.
22. Aman MG, Collier-Crespin A, Lindsay RL. Pharmacotherapy of disorders in mental retardation. Eur Child Adolesc Psych 2000;9:I98-I107.
23. Friedlander R, Lazar S, Klancnik J. Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities. Can J Psych 2001;46:741-745.
24. LaMalfa G, Lassi S, Bertelli M, Castellani A. Reviewing the use of antipsychotic drugs in people with intellectual disability. Hum Psychopharm 2006;21:73-89.
25. Masi G. Pharmacotherapy of pervasive developmental disorders in children and adolescents. CNS Drugs 2004; 18: 1031-1052.
26. Janowsky DS, Barnhill LJ, Shetty M, Davis JM. Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-in-jurious and destructive behaviors in mentally retarded adults. J Clin Psychopharmacol 2005;25:19-25.
27. McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B. Risperidone for the core symptoms of autism: Results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry 2005;162:1142-1148.
28. Janowsky DA, Shetty M, Barnhill J, Elamir B, Davis JM. Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviors in intellectually disabled adults: A retrospective, open-label, naturalistic trial. Intl J Neuropsychopharm 2005;8:37-48.
29. Symons FJ, Thompson A, Rodriguez MC. Self-injurious behavior & the efficacy of naltrexone treatment: A quantitative synthesis. Ment Retard Dev Disabil Res Rev 2004;10:193-200.
30. Buitelaar JK, Willemsen-Swinkels SHN. Medication treatment in subjects with autistic spectrum disorders. Eur Child Adolesc Psych 2000;9:I85-I97.
31. Kowatch RA, Bucci JP. Child and adolescent psychopharmacology: Mood stabilizers and anticonvulsants. Pediatr Clin Nort Am 1998;45:1173-1186.
32. Ruedrich SL, Crush L, Wilson J. Beta adrenergic blocking medications for aggressive or self-injurious mentally retarded persons. Am J Ment Retard 1990;95:110-119.
33. Kahng S, Iwata BA, Lewin A. Behavioral treatment of self-injury, 1964-2000. Am J Ment Retard 2002;107:212-221.
34. DeLeon IG, Fisher WW, Herman KM, Crosland KC. Assessment of a response bias for aggression over functionally equivalent appropriate behavior. J Appl Behav Anal 2000;33:73-77.
35. Hagopian LP, Adelinis JD. Response blocking with and without redirection for the treatment of pica. J Appl Behav Anal 2001;34:527-530.
36. Iwata BA, Dorsey MF, Slifer KJ, Bauman KE, Richman GS. Toward a functional analysis of self-injury. J Appl Behav Anal 1994;27:197-209.
37. Iwata BA, Pace GM, Dorsey Mf, Zarcone Jr, Volmmer TR, Smith RG. The functions of self-injurious behaviors; an experiemental-epidemiological analysis. J Appl Behav Anal 1994;27:215-240.
38. Hanley GP, Iwata BA, McCord BE. Functional analysis of problem behavior: A review. J Appl Behav Anal 2003;36:147-185.
39. Fisher WW, Piazza CC, Bowman LG, Hagopian LP, Owens JC, Slevin I. A comparison of two approaches for identifying reinforcers for persons with severe and profound disabilities. J Appl Behav 1992;25:491-498.
40. Hagopian LP, Crockett JL, VanStone M, De Leon IG, Bowman LG. Effects of noncontingent reinforcement on problem behavior and stimulus engagement: The role of satiation, extinction and alternative reinforcement. J Appl Behav Anal 2000;33:433-450.
41. Hagopian LP, Fisher WW, Thibault-Sullivan M, Acquisto J, LeBlanc LA. Effectiveness of functional communication training with and without extinction and punishment: A summary of 21 inpatient cases. J Appl Behav Anal 1998;31:211-235.
42. Kodak T, Miltenberger RG, Romaniuk C, The effects of differential negative reinforcement of other behavior and noncontingent escape on compliance. J Appl Behav Anal 2003;36:379-382.
43. Shore BA, Iwata BA, DeLeon IG, Kahng S, Smith RG. An analysis of reinforcer substitutability using object manipulation and self-injury as competing responses. J Appl Behav Anal 1997;30:21-40.
44. Kraus MF, Maki PM. Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: Case studies and review. J Neuropsychiatry Clin Neurosci 1997;9:222-230.
45. Tuinier S, Verhoeven WMA. Psychiatry and mental retardation: Towards a behavioural pharmacological concept. J Intellect Disabil Res 1993;37:16-25.